e-Update: News for University of Miami Miller School of Medicine Faculty and Staff

Up Front

The founders of the University's unique Industrial Ph.D. program are, from left, Sapna Deo, Ph.D., Zafar Nawaz, Ph.D., and Sylvia Daunert, Ph.D.

The founders of the University's unique Industrial Ph.D. program are, from left, Sapna Deo, Ph.D., Zafar Nawaz, Ph.D., and Sylvia Daunert, Ph.D.

Department of Biochemistry and Molecular Biology Launches First Online Industrial Ph.D. Degree

Leading the University of Miami into the next frontier of education, the Miller School’s Department of Biochemistry and Molecular Biology has established a unique degree program that will enable industry and government scientists to remain on the job – and in their labs – while earning a Doctor of Philosophy (Ph.D.) in Industrial Biochemistry and Molecular Biology.

Established by the department’s Sylvia Daunert, Ph.D., the Lucille P. Markey Chair of Biochemistry and Molecular Biology, Sapna Deo, Ph.D., Director of the Graduate Program, and Zafar Nawaz, Ph.D., Senior Associate Dean for Graduate and Postdoctoral Studies, this new degree is the first in the nation designed for full-time pharmaceutical, biotech or other industry or government laboratory scientists who are working in non-academic fields of biochemistry, molecular biology, biotechnology, nanotechnology, or medicine. Beginning this fall, candidates anywhere in the U.S. will have the opportunity to earn a Ph.D. from the Miller School through remote learning, rigorous research and dual university/company mentorship.

Read more about the industrial Ph.D. program »

More News

Stefan Glück, M.D., Ph.D.

View Video »

Stefan Glück, M.D., Ph.D.

Molecular Subtyping of Breast Cancer Shows Potential of Personalized Medicine

A new study at the Sylvester Comprehensive Cancer Center shows the potential of personalized medicine to guide therapy in early-stage, invasive breast cancer. The study in the rapidly advancing field of molecular subtyping was led by Stefan Glück, M.D., Ph.D., professor of medicine.

Writing in the journal Breast Cancer Research and Treatment, Glück and colleagues compared the findings of molecular subtyping to those of traditional clinical pathology to determine breast cancer type, which is used to help guide treatment.

“Molecular subtyping of early-stage breast cancer with the MammaPrint and BluePrint tests identifies a group of patients who do not benefit from neoadjuvant (preoperative) chemotherapy,” said Glück.

Read more about the findings »

Mauricio G. Cohen, M.D.

Mauricio G. Cohen, M.D.

Study Indicates Transradial PCI Growing in Popularity

Radial access for percutaneous coronary intervention is associated with reduced vascular complications, but the procedure, which gains entry via the wrist instead of the femoral artery, has been slow to take hold in the U.S. A new study co-authored by Mauricio G. Cohen, M.D., associate professor of medicine in the Cardiovascular Division, finds that this trend is changing.

Previous reports indicated that less than 2 percent of percutaneous coronary intervention (PCI) procedures in the nation were performed using the radial approach. Cohen and the team, which included physicians from Weill Cornell Medical College, Duke University, Vanderbilt University and University of Alabama at Birmingham, among others, examined trends and outcomes of nearly three million procedures performed between January 2007 and September 2012.

Read more about the study »

Sleep Center Featured in UHealth Discovery Series

From earplugs to exercise, Jennifer Diaz de Villegas had tried everything to conquer her ongoing insomnia. Then a friend told her about the UHealth Sleep Center. There, assistant professor Alexandre R. Abreu got to the root of Jennifer’s problem, helping the middle school guidance counselor learn that her insomnia was more psychological than anything else.

“He understood what I was experiencing and gave me the tools to help me manage my insomnia,” says Jennifer, who wore a watch that tracked her movements during sleep and kept a journal to monitor caffeine intake.

Read more about the UHealth Sleep Center »